Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
13.05
+0.09 (0.69%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Orthofix Medical Revenue
In the year 2024, Orthofix Medical had annual revenue of $799.49M with 7.08% growth. Orthofix Medical had revenue of $215.66M in the quarter ending December 31, 2024, with 7.61% growth.
Revenue (ttm)
$799.49M
Revenue Growth
+7.08%
P/S Ratio
0.62
Revenue / Employee
$494,735
Employees
1,616
Market Cap
508.46M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 799.49M | 52.85M | 7.08% |
Dec 31, 2023 | 746.64M | 285.93M | 62.06% |
Dec 31, 2022 | 460.71M | -3.77M | -0.81% |
Dec 31, 2021 | 464.48M | 57.92M | 14.25% |
Dec 31, 2020 | 406.56M | -53.39M | -11.61% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
OFIX News
- 4 weeks ago - Orthofix Receives 510(k) Clearance and CE Mark for TrueLok Elevate Transverse Bone Transport System - Business Wire
- 5 weeks ago - Orthofix Announces Appointment of Vickie Capps to Board of Directors - Business Wire
- 6 weeks ago - Orthofix to Participate in the 37th Annual Roth Conference - Business Wire
- 7 weeks ago - Orthofix Medical Inc. (OFIX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial Guidance - Business Wire
- 2 months ago - Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference - Business Wire
- 2 months ago - Top 2 Health Care Stocks That May Crash In February - Benzinga
- 2 months ago - Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results - Business Wire